(Q86725890)

English

Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform

scientific article published on 12 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jaroslaw Cwikla

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Marta Obara-Michlewska

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

object named as

Monika Szeliga

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Andrzej Cichocki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

12 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

100

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

74-78

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Identification of two human glutaminase loci and tissue-specific expression of the two related genes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Phosphate-activated glutaminase expression during tumor development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Expression of Gls and Gls2 glutaminase isoforms in astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Regulation of glutaminase activity and glutamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

A novel glutaminase isoform in mammalian tissues.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Glutaminase: a multifaceted protein not only involved in generating glutamate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Nuclear localization of L-type glutaminase in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Co-expression of glutaminase K and L isoenzymes in human tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Complexity and species variation of the kidney-type glutaminase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Glutamine: pleiotropic roles in tumor growth and stress resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

GEP-NETs UPDATE: Secreting gastro-enteropancreatic neuroendocrine tumours and biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Glutamine addiction: a new therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Epigenetic silencing of glutaminase 2 in human liver and colon cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.11.017

7 January 2021

Identifiers

10.1016/J.YEXMP.2015.11.017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26581715%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86725890&oldid=1985437813"